Aharon Y. Cohen

Unusual Adverse Effects of Immune Checkpoint Inhibitors: Autonomic Neuropathy, Palmoplantar Keratoderma, Reiter Syndrome & Myasthenia Gravis: A Case Series and Review of the Literature

N. Peled, R. Gibbs, A. Yakobson, 2020, International Journal of Innovative Research in Medical Science.

The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2nd/3rd-Generation ALK Tyrosine Kinase Inhibitors (TKIs)

A. Onn, J. Bar, N. Peled, 2022, Frontiers in Oncology.

Case Series: Point-of-Care Ultrasound on Oncology Inpatients with Respiratory Abnormalities

L. Fuchs, L. Roisman, Re'em Sadeh, 2020 .

Non-small cell lung cancer PDL1 >50%—should we go single or combo?

L. Roisman, N. Peled, W. Kian, 2020 .

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.

M. Mishaeli, H. Nechushtan, A. Onn, 2019, Clinical lung cancer.

Are we facing a cure in lung cancer?-KEYNOTE-001 insights.

L. Roisman, N. Peled, W. Kian, 2019, Annals of Translational Medicine.

Unexpected Adverse Events of Immune Checkpoint Inhibitors

O. Saleh, A. Yakobson, W. Shalata, 2023, Life.

Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors

O. A. Abu Saleh, A. Yakobson, W. Shalata, 2023, Journal of personalized medicine.